RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 1 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $113,000 | -86.3% | 20,520 | -55.5% | 0.00% | -76.9% |
| Q3 2021 | $824,000 | +943.0% | 46,076 | +345.5% | 0.01% | +550.0% |
| Q4 2020 | $79,000 | -66.9% | 10,343 | -78.3% | 0.00% | -80.0% |
| Q3 2020 | $239,000 | +132.0% | 47,772 | +178.2% | 0.01% | +100.0% |
| Q2 2020 | $103,000 | – | 17,173 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |